Institutional Investor recently released its prestigious 2022 Asia (ex-Japan) Executive Team ranking, recognizing Asia’s CEOs, CFOs, Investor Relations Officers, and Investor Relations programs that best uphold corporate governance standards and facilitate investment into their company. TPG clients Xpeng Inc. (NYSE: XPEV, HKEX: 9868), Bilibili Inc. (NASDAQ: BILI, HKEX: 9626), Xiaomi Corp. (HKEX: 1810), Everest Medicines Ltd. (HKEX: 1952), GDS Holdings Ltd. (NASDAQ: GDS, HKEX: 9698) and I-MAB (NASDAQ: IMAB) were honored to receive recognition for excellence across several categories including Best CEO, Best CFO, Best IR Professional, Best IR Program and Best ESG.
All public companies headquartered in Asia (ex-Japan) are eligible for inclusion in this annual ranking. Eligible companies’ investor relations programs are rated by nearly 5,000 buy- and sell-side investment professionals based on the following attributes: roadshows/conferences/meetings; IR team authority and credibility; accessibility of senior executives; responsiveness; earnings calls, business and market knowledge, timeliness of disclosure; and consistency and granularity of disclosure. Companies are also rated on their corporate ESG strategy, ESG engagement, and ESG disclosure.
The Piacente Group heartily congratulates Xpeng, Bilibili, Xiaomi, Everest Medicines, GDS Holdings and I-MAB on this commendation and their outstanding achievements. We are proud to support their industry-leading IR programs and their exemplary commitment to leadership, stewardship, and IR and ESG best practices.
Ranking Methodology: https://www.institutionalinvestor.com/research/11688/Methodology